Products

Prekallikrein/Kallikrein


Biochemistry

Synonym Fletcher Factor
Molecular mass 100.000 Da
Synthesis Liver
Plasma concentration 35 - 50 mg/l
Normal range 50 - 150% or 0.5 - 1.5 E/ml


Prekallikrein is the inactive precursor (zymogen, proenzyme) of kallikrein. After activation of the intrinsic coagulation system, prekallikrein - with participation of high molecular weight kininogen - is bound to negatively charged surfaces. Factor XIIa then activates it to kallikrein. In turn, kallikrein in a positive recoupling mechanism activates factor XII to factor XIIa.

Clinical significance

We differentiate between the hereditary deficiency, which occurs extremely seldom, and the acquired kallikrein deficiency. The acquired deficiency can be caused by interference of synthesis (serious liver disease) as well as by an increased consumption (e.g. DIC, septic shock, nephrotic syndrome).

Indication

  • Impairment of the kallikrein system
  • Suspected hereditary prekallikrein deficiency
  • Prolongation of the aPTT of unknown reason

Literature

  1. Gallimore MJ. Plasma Präkallikrein. Hämostaseologie 7, 166-171, 1987.
  2. Schmaier A et al. Activation of the Plasma Kallikrein/Kinin System on cells: A revised Hypothesis. Thromb Haemost 82, 226-233, 1999.
  3. De La Cadena R, Scott CF & Colman RW. Evaluation of a microassay for human plasma prekallikrein, J Lab Clin Med 109, 601-607, 1987.
  4. Friberger P, Aurell L & Claeson G. Chromogenic substrates for kallikreins and related enzymes. Agents and Actions Suppl. 9, 83-90, 1982.
  5. Scott C et al. A new assay for high molecular weight kininogen in human plasma using a chromogenic substrate. Thromb Res 48, 685-700, 1987.
  6. Karlsrud T et al. Evaluation of a Microassay for Human Kininogens as Cysteine Protease Inhibitors. J Pharm Meth 26, 113-124, 1991.
  7. Prassas I, Eissa A, Poda G, Diamandis EP. Unleashing the therapeutic potential of human kallikrein-related serine proteas-es. Nat Rev Drug Discov. Mar 14(3), 183-202, 2015.
  8. Potier L, Waeckel L, Richer C, Roussel R, Bouby N, Alhenc-Gelas F. Tissue kallikrein, blood pressure regulation, and hyper-tension: insight from genetic kallikrein deficiency. Biol Chem. Mar 394(3), 329-33, 2013.
Test kits
Chromogenic Assays

UNITEST Prekallikrein

Short Info Insert

UNITEST Kallikrein-Inhibitors

Short Info Insert

UNITEST Kallikrein-like Activity

Short Info Insert

Matched-Pair Antibody set

ELISA Prekallikrein

Short Info Insert

We are here for you

Haemochrom Diagnostica GmbH
Renteilichtung 1
45134 Essen
Germany

Phone: +49 (0)201 8 43 77-0
Fax: +49 (0)201 53 64 56
E-Mail: info@haemochrom.de

Send us a message